(Reuters) – The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc (AAPL.O), demonstrating a potential future role for wearable consumer technology in healthcare.
Researchers hope the technology can assist in early detection of atrial fibrillation, the most common form of irregular heart beat. Patients with untreated AF are five times more likely to have a stroke.
Sensor expert Sensirion and Quantex Arc Ltd have joined forces to develop an innovative wearable drug delivery IoT Platform, dubbed “Quantex 4C” for infusion therapies.
The new concept integrates connectivity with a modular drug delivery platform and enables continuous monitoring of the therapy with the help of a single use liquid flow sensor for safe ambulatory treatments.
Sensirion’s cost-effective LD20 single-use liquid flow sensor used for this concept study, is very compact and measures flow rates in the micro and millilitre per hour range with outstanding precision and reliability thanks to patented CMOSens Technology.
This non-invasive brain training solution uses an electroencephalogram (EEG) measurement device + Personalized brain exercises on an app. URGONight, the first non-invasive daytime brain training solution for a better sleep, is named as a CES 2019 Innovation Award Nominee in the Wearable Technology category.
How Does the Neurofeedback Method Work?
Developed by neuroscientists and sleep experts, URGONight uses the same technology previously only available to clinics and sleep researchers. Now, EEG-feedback therapy for sleep is available in the comfort of your own home.